BamSEC and AlphaSense Join Forces
Learn More

Lumos Pharma Inc.

Formerly NASDAQ: LUMO
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 8-K 25 pages Clinical Trial Funding Agreement
12/34/56
EX-10.2
from 8-K 12 pages Tender and Support Agreement
12/34/56
EX-10.1
from 8-K 21 pages Contingent Value Right Agreement
12/34/56
EX-10.20
from 10-K 7 pages Indemnity Agreement
12/34/56
EX-10.1
from 10-Q 21 pages Employment Agreement
12/34/56
EX-10.2
from 10-Q 3 pages Amendment No. 1 to Employment Agreement
12/34/56
EX-10.1
from 10-Q 3 pages Amendment No. 1 to Employment Agreement
12/34/56
EX-10.20
from 10-K 7 pages Indemnity Agreement
12/34/56
EX-10.1
from 8-K 45 pages Lumos Pharma, Inc Shares of Common Stock (Par Value $0.01 Per Share) Controlled Equity Offeringsm Sales Agreement
12/34/56
EX-10.2
from 10-Q 6 pages Amendment No. 1 to License Agreement
12/34/56
EX-10.1
from 10-Q 41 pages Asset Purchase Agreement by and Between Lumos Pharma, Inc. and Merck Sharp & Dohme Corp. July 27, 2020 Asset Purchase Agreement
12/34/56
EX-10.7
from 8-K/A 33 pages Asset Purchase Agreement
12/34/56
EX-10.6
from 8-K/A 38 pages License Agreement by and Between Merck Sharp & Dohme Corp. and Ammonett Pharma LLC Exclusive License Agreement
12/34/56
EX-10.2
from 8-K 17 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 18 pages Employment Agreement
12/34/56
EX-10.4
from 8-K 14 pages Lumos Pharma, Inc. Stock Option Agreement
12/34/56
EX-10.3
from 8-K 23 pages Lumos Pharma, Inc. 2016 Stock Plan
12/34/56
EX-10.2
from 8-K 20 pages Lumos Pharma, Inc. Stock Option Agreement
12/34/56
EX-10.1
from 8-K 18 pages Lumos Pharma, Inc. 2012 Equity Incentive Plan
12/34/56
EX-10.25
from 10-K 106 pages License and Collaboration Agreement
12/34/56